Mofegiline

![Mofegiline synthesis:[8][9]](/uploads/202501/27/Mofegiline_synthesis1836.png)
Mofegiline (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed.